Clinical Trial Update: Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial on post-transplant Epclusa (sofosbuvir/velpatasvir) treatment in patients with chronic hepatitis C after lung transplantation; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Lung Transplantation

Drugs mentioned

• Epclusa (sofosbuvir/velpatasvir)

Snippet

Sponsor: Duke University | Conditions: Hepatitis C, Chronic, Lung Transplant | Phase 4 | Status: TERMINATED | Results posted: 2019-09-11